Back to search

National and Kapodistrian University of Athens

Διερεύνηση της επίδρασης της ετερόζυγου β-μεσογειακής αναιμίας στα επίπεδα της HbA1c σε άτομα με και χωρίς σακχαρώδη διαβήτη

Abstract

dc:description

Background and Aims: To investigate the effect of heterozygous β-thalassemia on glycated hemoglobin (HbA1c) among individuals with and without diabetes mellitus (DM). Μaterials and Methods: Using a cross-sectional design, HbA1c levels were studied in two populations as follows: (a) between two subgroups of individuals without DM (100 consecutive carriers of β-thalassemia trait and 100 healthy controls) matched for age, gender and BMI, taking into account fasting serum glucose and fructosamine levels. The effect of hemoglobin concentration and HbF% on HbA1c was also examined. (b) between two subgroups of individuals with DM (77 consecutive carriers of β-thalassemia trait and 71 healthy controls) matched for age, gender, BMI, diabetes type and duration, and presence of complications, considering fasting serum glucose and fructosamine levels. The glycation gap (GG) was calculated. The effect of hemoglobin and bilirubin concentration, HbF(%) and relative reticulocyte count was examined. Results: In population (a), mean HbA1c level was almost identical in the two groups. Within the group of β-thalassemia, there was a positive correlation between HbA1c and hemoglobin concentration (r=0.455, p<0.001), which was not observed in controls. β-thalassemia carriers without anemia had slightly higher HbA1c levels compared to those with anemia (5.35% vs. 5.12% p<0.001, absolute difference (0.23%). In multivariable analysis, hemoglobin concentration, BMI and 1st degree family history of T2DM were significant predictors of HbA1c, while β-thalassemia carrier state was non-significant (p=0.07) but a positive correlation became significant after adjustment for HbF(%). In population (b) no significant effects of β-thalassemia carrier state was ascertained on either HbA1c level or GG despite the considerable effects of erythrocyte turnover-related parameters. Conclusions: The effect of heterozygous β-thalassemia and β-thalassemia trait-associated anemia on HbA1c among individuals without DM is of negligible clinical significance while no effect of heterozygous β-thalassemia on HbA1c values is observed among individuals with DM. These findings advocate for the clinical use of HbA1c as a diagnostic criterion for diabetes mellitus and for long-tern therapeutic monitoring among β-thalassemia carriers.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsilingiris, Dimitrios
  • Τσιλιγγίρης, Δημήτριος

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/47628

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsilingiris, Dimitrios; Τσιλιγγίρης, Δημήτριος. Διερεύνηση της επίδρασης της ετερόζυγου β-μεσογειακής αναιμίας στα επίπεδα της HbA1c σε άτομα με και χωρίς σακχαρώδη διαβήτη. National and Kapodistrian University of Athens, 2020. http://hdl.handle.net/10442/hedi/47628